URGENT: We Have a Breakthrough. We Can't Lose This Chance.

A groundbreaking study has revealed a potential new weapon against Clear Cell Sarcoma: the combination of devimistat and hydroxychloroquine may actually stop CCS growth and spread.

Building on this incredible promise, our clinical trial (NCT04593758) has successfully and safely completed Phase 1. The hope is real, and it's here.

Now, we stand on the brink of Phase 2, a trial that will include adolescents as young as 12. This could be the breakthrough our community has been fighting for.

But we face a critical deadline. We have two weeks to secure the funds for the Phase 2 drug supply.

Without immediate support, this vital trial cannot move forward. Promising research could stall, and hope for a treatment could be delayed for years.

We cannot let this happen. Every donation, right now, gets us closer to the finish line.

Devimistat + Hydroxychloroquine Trial

By Clear Cell Sarcoma Foundation

Devimistat + Hydroxychloroquine Trial

Team Members